USNU — US Neurosurgical Holdings Cashflow Statement
0.000.00%
- $6.96m
- $5.21m
Annual cashflow statement for US Neurosurgical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.142 | 0.533 | -0.973 | -1.57 | -0.816 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.42 | 0.843 | 0.505 | 0.47 | 0 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.317 | -0.276 | 0.642 | -0.311 | -0.075 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.55 | 1.12 | 0.174 | -1.41 | -0.891 |
Capital Expenditures | 0 | — | — | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.334 | 0.479 | 0.063 | 0.772 | -0.18 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.334 | 0.479 | 0.063 | 0.772 | -0.18 |
Financing Cash Flow Items | — | — | — | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.4 | -0.901 | -0.089 | 0 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.184 | 0.695 | 0.148 | -0.641 | -1.07 |